mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer

Extensive preclinical studies have identified mammalian target of rapamycin (mTOR) activation as a frequent molecular signature underlying head and neck squamous cell carcinoma (HNSCC), including the distinct clinical subtype that is human papillomavirus (HPV) related, and have demonstrated the pote...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joseph D. Coppock, John H. Lee
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2016
Materias:
Acceso en línea:https://doaj.org/article/6ea55a55dc194ba9983b051ef865fc79
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!